Kalvista Pharmaceuticals
Price & Volume
Stats
See more52W Range | $7.30-$15.50 |
Market Cap | $589M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $3.8M |
Revenue Growth (YoY) | 30.7% |
Gross Profit (12 Mos) | -$90.9M |
Diluted EPS | -$3.68 |
News
See moreYahoo Finance • last year
16 Most Promising Long-Term Stocks According to Analysts
Yahoo Finance • 2 years ago
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
Yahoo Finance • 2 years ago
KalVista Pharmaceuticals Provides Progress Updates on Sebetralstat Development
Yahoo Finance • 2 years ago
Down More Than 60%: Analysts Say Buy These 3 Beaten-Down Stocks Before They Rebound
About
CEO | Mr. Benjamin L. Palleiko |
Address | 55 Cambridge Parkway, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 150 |
